معرفی
Dr. Manu De Rycker is a Senior Lecturer (Teaching and Research) and Principal Investigator at the Drug Discovery Unit, University of Dundee. He serves as Head of Pathogen Biology, Portfolio Leader for Kinetoplastid and Antifungal Drug Discovery, and Deputy Head of both the Drug Discovery Unit and Division. His work spans parasitology, drug discovery, and infectious diseases, with a focus on Trypanosoma cruzi (Chagas disease) and Leishmania species (visceral leishmaniasis).
- Active projects (2025) include preclinical development for Chagas disease and antifungal research
- Collaborations with GSK Tres Cantos Open Lab Foundation, University of Arizona, and University of Glasgow
- Key research themes: parasite biology, proteasome inhibition, and drug target validation
His recent publications analyze:
- Mechanistic pharmacology of parasitic enzymes
- Drug binding site dynamics
- Combination therapies for chronic Chagas disease
- Structural biology approaches to drug design
Scientific awards:
- Industry and Academic Collaboration Award (2023)
- DNDi Project of the Year 2023
He contributes to peer-review for journals like Cell Chemical Biology and eLife, and participates in conferences on AI-driven anti-parasitic drug discovery.
۰مقاله ثبتشده
